Le Lézard
Classified in: Health, Science and technology
Subject: MAT

HempFusion® Launches Sitewide "Black Friday" Sale!


DENVER, CO, Nov. 26, 2019 /PRNewswire/ - HempFusion® ("the Company"), a leading Hemp/CBD company in the United States with distribution of its family of brands to over 3,900 retailers across 47 states, is pleased to announce the launch of its sitewide "Black Friday" sale featuring holiday Whole Food Hemp ComplexTM CBD gifts at amazing prices.

HempFusion®  products (CNW Group/Hemp Fusion)

Shoppers using a discount code will enjoy 30% off all HempFusion products starting on Friday, November 29, 2019 through Monday December 2, 2019. The discount code will be announced to subscribers on HempFusion's mailing list and across the Company's Instagram, Twitter and Facebook accounts this Friday.

"We are incredibly excited to launch our sitewide Black Friday sale. This provides new customers with a chance to try a variety of our Whole Food Hemp ComplexTM CBD products at a significant discount," stated Ian deQueiroz, HempFusion CEO and co-founder. "Existing customers can enjoy savings on their favorite HempFusion products or take this opportunity to try something new", continued deQueiroz.

HempFusion's leading CBD based products aim to illustrate hemp as the ultimate Superfood with a blend of dozens of amazing & powerful constituents including cannabinoids, terpenes like ß-Caryophillene, and Omegas 3, 6 & 9. Rather than isolated or spiked CBD, HempFusion® uses hemp extracted with a unique CO2 Extraction method called the HO-PETM (Hemp One-Pass ExtractionTM) process to protect these constituents during extraction.

HempFusion's Whole Food Hemp ComplexTM is a blend of CBD and other cannabinoids along with additional plant-based terpenes and omegas formulated to optimize the ensemble effect of all beneficial compounds. HempFusion's complete product offering, store locator and additional information can be accessed here.

ABOUT HEMPFUSION

HempFusion is a premium hemp-based cannabidiol ("CBD") wellness Company with distribution of its family of brands to over 3,900 retailers across 47 US states. The Company strives to maintain the highest level of compliance in the industry. HempFusion's wide variety of 25+ CBD products with a full spectrum of cannabinoids and other constituents are sourced from quality phytocompounds manufactured under cGMP standards designed to attain efficacy and safety. HempFusion's primary focus is formulating and marketing premium consumer-specific product lines with various delivery methods, across multiple distribution platforms. The Company's CBD products are based on a proprietary Whole Food Hemp Complextm and are available through independently owned and national chain health food stores, or by visiting www.hempfusion.com.

Hempfusion Inc. (CNW Group/Hemp Fusion)

SOURCE Hemp Fusion


These press releases may also interest you

at 03:05
VIAVI Solutions ("VIAVI") notes the announcement made by Keysight Technologies, Inc. ("Keysight") and Spirent Communications plc ("Spirent") on March 28, 2024, of a recommended cash acquisition of Spirent by Keysight. VIAVI believes that its...

at 03:04
Policybazaar, India's leading online insurance marketplace, is witnessing a significant increase in non-resident Indians (NRIs) choosing term insurance from India via its platform. This surge is driven by the unparalleled ease, affordability and...

at 03:00
TRON Forum (Chair: Ken Sakamura, Professor Emeritus of the University of Tokyo) is pleased to announce that four microcontroller manufacturers, Infineon Technologies Japan K.K. (President & CEO: Ikuya Kawasaki), STMicroelectronics K.K. (Country...

at 02:00
OKX, a leading crypto exchange by trading volume and a leading Web3 technology company, has issued updates for March 29, 2024. OKX...

at 00:30
Frost & Sullivan recently researched the data center colocation services industry and, based on its findings, recognizes STT GDC India with the 2023 Indian Company of the Year Award. STT GDC India is a pioneer data center solutions provider that...

at 00:25
Shanghai Junshi Biosciences Co., Ltd ("Junshi Biosciences," HKEX: 1877; SSE: 688180), a leading innovation-driven biopharmaceutical company dedicated to the discovery, development, and commercialization of novel therapies, announced its financial...



News published on and distributed by: